Cargando…
De-escalation of antifungal treatment in critically ill patients with suspected invasive Candida infection: incidence, associated factors, and safety
BACKGROUND: Antifungal treatment is common in critically ill patients, but only a small proportion of patients receiving antifungals have a proven fungal infection. However, antifungal treatment has side effects such as toxicity, emergence of resistance, and high cost. Moreover, empirical antifungal...
Autores principales: | Jaffal, Karim, Poissy, Julien, Rouze, Anahita, Preau, Sébastien, Sendid, Boualem, Cornu, Marjorie, Nseir, Saad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908771/ https://www.ncbi.nlm.nih.gov/pubmed/29675561 http://dx.doi.org/10.1186/s13613-018-0392-8 |
Ejemplares similares
-
The Changing Landscape of Invasive Fungal Infections in ICUs: A Need for Risk Stratification to Better Target Antifungal Drugs and the Threat of Resistance
por: Poissy, Julien, et al.
Publicado: (2022) -
Relationship between digestive tract colonization and subsequent ventilator-associated pneumonia related to ESBL-producing Enterobacteriaceae
por: Houard, Marion, et al.
Publicado: (2018) -
Application of Mass Spectrometry Technology to Early Diagnosis of Invasive Fungal Infections
por: Mery, Alexandre, et al.
Publicado: (2016) -
Factors predicting prolonged empirical antifungal treatment in critically ill patients
por: Zein, Mohamed, et al.
Publicado: (2014) -
Impact of antifungal treatment on Candida–Pseudomonas interaction: a preliminary retrospective case–control study
por: Nseir, Saad, et al.
Publicado: (2006)